Redsense Medical AB (XSAT:REDS) Moat Score: 0/10 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:REDS Redsense Medical AB XSAT:REDS
54 GF Score
Price kr4.42
GF Value kr6.86
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Redsense Medical AB Moat Score?

Redsense Medical AB has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Redsense Medical AB has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Redsense Medical AB might have No Moat - No discernible moat.

Redsense Medical AB  (XSAT:REDS) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Redsense Medical AB Moat Score Related Terms

XSAT:REDS
54GF Score
Redsense Medical AB XSAT:REDS
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Redsense Medical AB (XSAT:REDS) Overvalued in 2026?

Based on GuruFocus' analysis, Redsense Medical AB stock appears to be undervalued. The current stock price of kr4.42 is trading 35.6% below its estimated GF Value™ of kr6.86. GuruFocus considers Redsense Medical AB to be Possible Value Trap.

Key valuation signals for XSAT:REDS:

  • Moat Score: 0
  • GF Value™: kr6.86 vs. price of kr4.42 (35.6% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the XSAT:REDS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redsense Medical AB Business Description

Address Storgatan 36, Halmstad, SWE, 302 43
Redsense Medical AB manufactures and sells blood loss detection devices in Sweden. The company has developed a monitoring system that can detect the first sign of a blood leak using patented fiber optic technology. The products of the company include Alarm Unit, Venous Needle Patch, Sensor Patch, and others.
54GF Score

Get the complete analysis for XSAT:REDS

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr4.42
Price
kr6.86
GF Value